444 related articles for article (PubMed ID: 9224728)
1. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
Nagasaki T; Hino M; Inaba M; Nishizawa Y; Morii H; Otani S
Arch Biochem Biophys; 1997 Jul; 343(2):181-7. PubMed ID: 9224728
[TBL] [Abstract][Full Text] [Related]
2. Modulation by cAMP of 1alpha,25-dihydroxyvitamin D3 sensitivity of murine erythroleukemia cells.
Waki M; Inaba M; Hiura Y; Nagasaki T; Imanishi Y; Ishimura E; Otani S; Nishizawa Y
Arch Biochem Biophys; 2001 Jul; 391(2):265-70. PubMed ID: 11437358
[TBL] [Abstract][Full Text] [Related]
3. Involvement of polyamines in the proliferation of bovine parathyroid cells.
Imanishi Y; Inaba M; Nishizawa Y; Morii H; Otani S
Miner Electrolyte Metab; 1995; 21(1-3):197-200. PubMed ID: 7565449
[TBL] [Abstract][Full Text] [Related]
4. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
5. Role of putrescine in interleukin 1 beta production in human histiocytic lymphoma cell line U937.
Tahara H; Otani S; Matsui-Yuasa I; Koyama H; Nishizawa Y; Morisawa S; Morii H
J Cell Physiol; 1991 May; 147(2):199-207. PubMed ID: 2040654
[TBL] [Abstract][Full Text] [Related]
6. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of beta-globin, transferrin receptor, and ornithine decarboxylase in Friend murine erythroleukemia cells inhibited by alpha-difluoromethylornithine.
Klinken SP; Billelo J; Bauer S; Morse HC; Thorgeirsson SS
Cancer Res; 1987 May; 47(10):2638-44. PubMed ID: 2436752
[TBL] [Abstract][Full Text] [Related]
8. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
10. Effects of transforming growth factor-beta and activin A on vitamin D3-induced monocytic differentiation of myeloid leukemia cells.
Okabe-Kado J; Honma Y; Hayashi M; Hozumi M
Anticancer Res; 1991; 11(1):181-6. PubMed ID: 2018352
[TBL] [Abstract][Full Text] [Related]
11. D,L-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, induces differentiation in MEL cells.
Choudhary SK; Sharma D; Dixit A
Cell Biol Int; 1999; 23(7):489-95. PubMed ID: 10728786
[TBL] [Abstract][Full Text] [Related]
12. A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3.
Kanatani Y; Makishima M; Ishikawa I; Ogasawara Y; Kawahara N; Motoyoshi K; Nagata N; Honma Y
Exp Hematol; 1998 Mar; 26(3):198-206. PubMed ID: 9502615
[TBL] [Abstract][Full Text] [Related]
13. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
[TBL] [Abstract][Full Text] [Related]
15. Effects of polyamine depletion on proliferation and differentiation of murine erythroleukemia cells.
Sugiura M; Shafman T; Kufe D
Cancer Res; 1984 Apr; 44(4):1440-4. PubMed ID: 6423275
[TBL] [Abstract][Full Text] [Related]
16. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
Boyan BD; Posner GH; Greising DM; White MC; Sylvia VL; Dean DD; Schwartz Z
J Cell Biochem; 1997 Sep; 66(4):457-70. PubMed ID: 9282324
[TBL] [Abstract][Full Text] [Related]
17. c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs.
Takasu H; Sugita A; Uchiyama Y; Katagiri N; Okazaki M; Ogata E; Ikeda K
J Clin Invest; 2006 Feb; 116(2):528-35. PubMed ID: 16424941
[TBL] [Abstract][Full Text] [Related]
18. 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells.
Fernandez-Garcia NI; Palmer HG; Garcia M; Gonzalez-Martin A; del Rio M; Barettino D; Volpert O; Muñoz A; Jimenez B
Oncogene; 2005 Sep; 24(43):6533-44. PubMed ID: 16007183
[TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
20. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
